Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mast Cell Protease 8 Inhibitors

Mast Cell Protease 8 (MCP-8) inhibitors, as per current scientific understanding, are not exclusively available. However, the compounds listed here demonstrate potential for indirectly inhibiting or influencing MCP-8 activity by targeting related serine proteases or pathways within mast cells. Serine proteases, a category to which MCP-8 belongs, are crucial in various physiological processes including digestion, immune response, and blood coagulation. The inhibitors like Gabexate Mesilate, Nafamostat Mesilate, and Camostat Mesilate, are broad-spectrum and target enzymes like trypsin, kallikrein, and plasmin. These enzymes share functional similarities with MCP-8, suggesting that their inhibition might have a downstream effect on MCP-8 activities.

The use of these inhibitors provides insight into the complexity of protease regulation within biological systems, particularly in mast cells. Mast cells, known for their role in allergy and inflammation, contain various serine proteases, including MCP-8. By inhibiting enzymes that are part of the same family or pathway, one can indirectly influence the activity of MCP-8. This approach is often necessary in cases where direct inhibitors are not available. For instance, Aprotinin and Leupeptin Hemisulfate demonstrate this indirect inhibition approach by targeting related proteases. Other compounds like E-64 and Pepstatin A, though not serine protease inhibitors, contribute to the broader protease inhibition landscape, potentially affecting MCP-8 activity in an indirect manner. In conclusion, while direct MCP-8 inhibitors are not currently identified, the chemicals listed offer a strategic approach to modulate related protease activities and pathways. The understanding of these compounds and their effects on serine proteases aids in exploring potential avenues for influencing MCP-8 activity, underscoring the intricate network of proteases and their inhibitors in biological systems. This knowledge is crucial for advancing research in areas related to mast cell physiology and associated disorders.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gabexate mesylate

56974-61-9sc-215066
5 mg
$100.00
(0)

A synthetic serine protease inhibitor, Gabexate Mesilate targets various proteases including trypsin, kallikrein, and plasmin, potentially affecting MCP-8 related pathways by reducing proteolytic activities in mast cells.

Nafamostat mesylate

82956-11-4sc-201307
sc-201307A
10 mg
50 mg
$82.00
$306.00
4
(1)

Nafamostat Mesilate is a broad-spectrum serine protease inhibitor, known for inhibiting factors like thrombin and trypsin, which could indirectly affect MCP-8 activity by modulating related protease activity in mast cells.

Camostat mesylate

59721-29-8sc-203867
sc-203867A
sc-203867B
sc-203867C
sc-203867D
sc-203867E
10 mg
50 mg
500 mg
1 g
10 g
100 g
$43.00
$183.00
$312.00
$624.00
$2081.00
$4474.00
5
(0)

This serine protease inhibitor, Camostat Mesilate, specifically inhibits trypsin, kallikrein, and plasmin, which may contribute to the regulation of proteases in mast cells, thereby indirectly influencing MCP-8.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

Aprotinin, a polypeptide inhibitor, predominantly inhibits trypsin, chymotrypsin, and plasmin, and could indirectly impact MCP-8 activity through its effect on related serine proteases in mast cells.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Acting as an inhibitor for several proteases like trypsin, plasmin, and papain, Leupeptin Hemisulfate may have an indirect impact on MCP-8 by modulating proteolytic processes within mast cells.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

E-64 is a cysteine protease inhibitor, known to inhibit cathepsins B, H, and L, which could indirectly affect MCP-8 by altering protease dynamics within mast cells.

Tranexamic acid

1197-18-8sc-204921
sc-204921A
5 g
10 g
$29.00
$50.00
10
(1)

Tranexamic Acid, an antifibrinolytic agent, inhibits plasminogen activation and could indirectly affect MCP-8 activity by altering protease pathways in mast cells.

Benzamidine

618-39-3sc-233933
10 g
$292.00
1
(0)

Primarily a trypsin inhibitor, Benzamidine Hydrochloride could potentially influence MCP-8 by modulating serine protease activities in mast cells.

Chymostatin

9076-44-2sc-202541
sc-202541A
sc-202541B
sc-202541C
sc-202541D
5 mg
10 mg
25 mg
50 mg
100 mg
$156.00
$260.00
$640.00
$1186.00
$2270.00
3
(1)

Chymostatin is a chymotrypsin inhibitor and might indirectly affect MCP-8 activity by influencing related protease functions in mast cells.

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

AEBSF Hydrochloride is a broad-spectrum serine protease inhibitor, potentially impacting MCP-8 by altering related protease activities in mast cells.